Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Intravenous Catheters Market Size & Growth Forecast 2027–2036, By Segments (Product Type, Lumen, End-use, Gauge Size, Material), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 4283| Published Date: Aug-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Intravenous Catheters Market size was worth USD 11.4 Billion in 2026 and is expected to grow at 8.27% CAGR between 2027 and 2036, exceeding USD 25.23 Billion by 2036. The industry revenue for 2027 is calculated at USD 12.2 Billion.

Base Year Value (2025)
USD 10.74 Billion
CAGR (2026-2035)
7.9%
Forecast Year Value (2035)
USD 22.97 Billion
Historical Data Period
2021-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Intravenous Catheters Market Intelligence Snapshot

Regional Market Dynamics

  • North America held 35.64% in 2026, supported by advanced hospital infrastructure, high intravenous therapy utilization, extensive care networks, and strong adoption of modern catheter technologies.
  • Asia Pacific is expanding through healthcare infrastructure investment, rising hospital admissions, growing chronic disease care, expanded critical services, and increasing adoption of advanced catheter solutions.

Segment Momentum

  • Peripherally inserted central catheters accounted for 60.84% of the market in 2026 due to their suitability for long-term intravenous therapy, supporting repeated treatment while improving patient comfort and reducing frequent needle insertions.
  • Double lumen catheters are gaining adoption because they enable simultaneous delivery of multiple therapies through a single access device, improving treatment efficiency and reducing the need for multiple catheter insertions.

Market Expansion Drivers

  • Increasing demand for intravenous therapies across acute and chronic care settings
  • Growing chronic disease prevalence accelerating long-term vascular access requirements
  • Enhanced catheter safety and infection-control technologies improving healthcare adoption rates

Leading Market Participants

  • Key players in the intravenous catheters market include Becton, Dickinson and Company (United States), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), Teleflex Incorporated (United States), Terumo Corporation (Japan), Boston Scientific Corporation (United States), ICU Medical, Inc. (United States), Nipro Corporation (Japan), Smiths Medical (United Kingdom), Vygon (France)

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 11.4 Billion
  • 2027 Estimated Market Size: USD 12.2 Billion
  • Projected Market Size: USD 25.23 Billion by 2036
  • Growth Forecast: 8.27% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Peripherally Inserted Central Catheter (Product Type) | Single Lumen (Lumen) | Hospitals (End-use) | 21G – 22G (Gauge Size) | Silicone (Material)
  • Emerging Opportunity Segment: Peripherally Inserted Central Catheter (Product Type) | Double Lumen (Lumen) | Ambulatory Surgical Centers (End-use) | 21G – 22G (Gauge Size) | Polyurethane (Material)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Increasing demand for intravenous therapies across acute and chronic care settings

The expanding use of intravenous administration for medications, fluids, nutrition, and supportive therapies across hospitals and outpatient facilities is creating sustained demand for reliable vascular access devices. The intravenous catheters market growth is supported by the increasing need for efficient delivery of treatments in emergency care, surgical procedures, critical care, and long-term disease management. Healthcare providers continue to prioritize catheter solutions that improve procedural efficiency while ensuring consistent access for a wide range of therapeutic interventions.

Growing chronic disease prevalence accelerating long-term vascular access requirements

Rising numbers of patients requiring ongoing medical treatment are increasing the importance of dependable vascular access for repeated therapeutic administration. This trend will drive the intravenous catheters market demand as chronic disease management frequently involves prolonged infusion therapies, regular medication delivery, and continuous clinical monitoring. Healthcare systems are therefore expanding the adoption of catheter technologies designed to support long-term use while improving patient comfort and reducing the need for repeated vascular access procedures.

Enhanced catheter safety and infection-control technologies improving healthcare adoption rates

Innovation in catheter design is helping healthcare providers address concerns related to patient safety, device-associated complications, and infection prevention. As these advancements become more widely available, the intravenous catheters market is benefiting from greater adoption of technologies that improve insertion accuracy, reduce contamination risks, and support safer clinical workflows. Features focused on minimizing accidental needle injuries, enhancing secure catheter stabilization, and strengthening infection-control practices are increasingly influencing purchasing decisions across healthcare facilities.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Increasing demand for intravenous therapies across acute and chronic care settings 2% High North America, Europe High Near Term
Growing chronic disease prevalence accelerating long-term vascular access requirements 1.8% Moderate Asia Pacific, North America High Near Term
Enhanced catheter safety and infection-control technologies improving healthcare adoption rates 1.5% High Europe, North America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
35.64% Market Share in 2026

North America (Largest Region)

North America dominated the intravenous catheters market with a 35.64% share in 2026, supported by advanced hospital infrastructure, high utilization of intravenous therapies, and widespread adoption of modern medical devices. The region's substantial hospital and outpatient care networks generate consistent demand for intravenous access across surgical, emergency, oncology, and chronic disease treatment settings. Increasing emphasis on patient safety and infection prevention is also encouraging healthcare facilities to adopt catheter technologies designed to improve insertion, reduce complications, and enhance clinical efficiency. In addition, established healthcare systems and strong awareness of advanced catheterization practices reinforce the region's leading position.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is projected to be the fastest-growing region, supported by expanding healthcare facilities, increasing hospital admissions, and improving access to modern medical technologies. Growing investments in healthcare infrastructure are enabling hospitals and treatment centers to strengthen intravenous therapy capabilities, particularly across emerging economies. The rising burden of chronic diseases and the expansion of surgical, emergency, and critical care services are further increasing the need for reliable vascular access devices. Greater awareness of infection-control practices and the gradual modernization of clinical procedures are also encouraging healthcare providers to transition toward more advanced intravenous catheter solutions, supporting the region's growth trajectory.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Infection Prevention Priority

The U.S. intravenous catheters market increasingly emphasizes products that reduce catheter-related complications while improving patient safety. Healthcare facilities continue adopting advanced catheter technologies with enhanced securement, antimicrobial features, and improved insertion efficiency.

Germany 🇩🇪

Quality Care Standardization

Germany prioritizes intravenous catheters that support standardized vascular access practices across hospitals and outpatient settings. Demand increasingly focuses on devices that improve procedural reliability, minimize complications, and enhance clinician workflow efficiency.

Japan 🇯🇵

Precision Vascular Access

Japan emphasizes high-quality intravenous catheters designed for reliable vascular access across acute and long-term care settings. Healthcare providers increasingly value ergonomic device designs that improve insertion accuracy and patient comfort during routine clinical use.

South Korea 🇰🇷

Smart Clinical Integration

South Korea advances the intravenous catheters market by integrating modern vascular access devices into digitally enabled healthcare environments. Hospitals increasingly prioritize catheter solutions that support efficient workflows, patient safety, and consistent clinical performance.

France 🇫🇷

Hospital Safety Optimization

France focuses on intravenous catheters that strengthen infection control practices and improve vascular access outcomes in hospital environments. Procurement decisions increasingly favor products offering dependable performance, ease of use, and compliance with evolving clinical protocols.

Italy 🇮🇹

Reliable Acute Care Access

Italy continues adopting intravenous catheters that support dependable vascular access across emergency, surgical, and inpatient care. Healthcare providers increasingly seek devices that balance procedural simplicity with enhanced patient safety and consistent clinical performance.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Intravenous Catheters Market Share (%), Product Type, 2025

Peripherally Inserted Central Catheter
Central venous catheter
Midline peripheral catheter

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Type Segment Analysis: Peripherally Inserted Central Catheter (Largest & Fastest-Growing Segment)

The intravenous catheters market was led by the peripherally inserted central catheter segment, which accounted for 60.84% in 2026, while also emerging as the fastest-growing product type. Its leadership is driven by its suitability for long-term intravenous therapy, allowing repeated administration of medications, fluids, and nutritional support while minimizing the need for frequent needle insertions. These catheters are widely utilized for patients requiring prolonged treatment, including chemotherapy, antimicrobial therapy, and critical care. Growing emphasis on improving patient comfort, reducing vascular complications, and supporting efficient long-term treatment protocols continues to strengthen demand for peripherally inserted central catheters across healthcare settings.

Lumen Segment Analysis: Single Lumen (Largest Segment) vs Double Lumen (Fastest-Growing Segment)

The single lumen segment accounted for the largest share of 42.82% in 2026 owing to its broad use in routine intravenous therapies where a single access point is sufficient for medication delivery or fluid administration. Healthcare providers often prefer single lumen catheters because they are less complex, easier to manage, and associated with streamlined clinical workflows. Their widespread application across general patient care continues to support their dominant market position.

The double lumen segment is anticipated to witness the fastest growth as healthcare facilities increasingly require simultaneous administration of multiple therapies through a single vascular access device. The ability to deliver incompatible medications or fluids through separate lumens enhances treatment efficiency while reducing the need for multiple catheter insertions. Rising demand for advanced patient management and more flexible infusion capabilities is expected to accelerate adoption of double lumen catheters.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

The hospitals segment dominated the intravenous catheters market, accounting for 58.62% in 2026. Its leading position is supported by the high volume of inpatient procedures, emergency care, intensive care services, and complex treatments requiring dependable intravenous access. Hospitals also maintain specialized clinical teams and infrastructure capable of managing a wide range of catheter-based therapies, contributing to sustained demand across diverse medical specialties.

The ambulatory surgical centers segment is expected to register the fastest growth due to the increasing preference for minimally invasive procedures and same-day surgical care. These facilities emphasize efficient patient turnover, shorter recovery periods, and cost-effective treatment, creating strong demand for reliable intravenous catheter solutions that support safe and streamlined clinical procedures.

Segment Sub-Segment Largest Segment Fastest Growing
Product Type Midline Peripheral Catheter, Peripherally Inserted Central Catheter, Central Venous Catheter Peripherally Inserted Central Catheter Peripherally Inserted Central Catheter
Lumen Single Lumen, Double Lumen, Multi-lumen Single Lumen Double Lumen
End-use Hospitals, Ambulatory Surgical Centers, Others Hospitals Ambulatory Surgical Centers
Gauge Size 14G – 16G, 17G – 18G, 19G – 20G, 21G – 22G, 23G+ 21G – 22G 21G – 22G
Material Polyurethane, Silicone, PVC, Others Silicone Polyurethane
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the intravenous catheters market:

  1. Becton Dickinson and Company (United States)
  2. B. Braun Melsungen AG (Germany)
  3. Medtronic plc (Ireland)
  4. Teleflex Incorporated (United States)
  5. Terumo Corporation (Japan)
  6. Boston Scientific Corporation (United States)
  7. ICU Medical, Inc. (United States)
  8. Nipro Corporation (Japan)
  9. Smiths Medical (United Kingdom)
  10. Vygon (France)

Demand for safer and more efficient vascular access is reshaping competition in the intravenous catheters market, encouraging manufacturers to move beyond standard device offerings and prioritize usability, infection prevention, and procedural reliability. Product development increasingly emphasizes materials that improve patient comfort while supporting consistent clinical performance across diverse care environments. Suppliers are also strengthening their position through comprehensive training resources, quality assurance systems, and manufacturing capabilities that enable healthcare providers to standardize catheter selection without compromising regulatory compliance or operational efficiency.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Becton, Dickinson and Company Apr-24 Becton, Dickinson and Company introduced the UltraTouch blood collection device designed to minimize patient discomfort through single-prick success. This innovation addresses procedural anxiety, lowers first-time blood collection complications, and supports reliable clinical diagnostics without treatment delays.
Becton, Dickinson and Company Nov-23 Becton, Dickinson and Company launched a needle-free blood draw technology compatible with integrated and long peripheral intravenous catheters. This addition to the company's PIVO portfolio expands its product line and enhances patient access capabilities within acute care vascular management.
B. Braun Medical Inc. Jul-22 B. Braun Medical Inc. launched the Introcan Safety 2 IV Catheter equipped with an integrated one-time blood control feature. The technological enhancement is engineered to mitigate the incidence of needlestick injuries among clinical operators, improving safety standards during routine infusion therapy.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Intravenous Catheters Market — Custom Segments

Segment Sub-Segment
No segment data available.

Intravenous Catheters Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market valuation of intravenous catheters?

The market valuation of the intravenous catheters is USD 12.2 Billion in 2027.

What is the forecasted size of the intravenous catheters industry?

Intravenous Catheters Market size was worth USD 11.4 Billion in 2026 and is expected to grow at 8.27% CAGR between 2027 and 2036, exceeding USD 25.23 Billion by 2036.

Which healthcare trends are driving long-term demand for intravenous catheter technologies?

Rising chronic disease management and expanding intravenous therapy use across acute and outpatient settings are increasing demand for dependable vascular access. Healthcare providers are prioritizing catheter technologies that support prolonged treatment while improving patient comfort and procedural efficiency.

How are safety and infection-control innovations influencing purchasing decisions in the intravenous catheters market?

Healthcare facilities increasingly favor catheter solutions that reduce contamination risks, improve insertion accuracy, and enhance workflow safety. Features supporting infection prevention, secure stabilization, and reduced needle injuries are becoming key procurement considerations.

Why do peripherally inserted central catheters dominate the intravenous catheters market?

Peripherally inserted central catheters accounted for 60.84% of the market in 2026 due to their suitability for long-term intravenous therapy, supporting repeated treatment while improving patient comfort and reducing frequent needle insertions.

Why are double lumen catheters the fastest-growing lumen segment?

Double lumen catheters are gaining adoption because they enable simultaneous delivery of multiple therapies through a single access device, improving treatment efficiency and reducing the need for multiple catheter insertions.

Why does North America hold the largest share of the intravenous catheters market?

North America held 35.64% in 2026, supported by advanced hospital infrastructure, high intravenous therapy utilization, extensive care networks, and strong adoption of modern catheter technologies.

What is driving faster intravenous catheter market growth in Asia Pacific?

Asia Pacific is expanding through healthcare infrastructure investment, rising hospital admissions, growing chronic disease care, expanded critical services, and increasing adoption of advanced catheter solutions.

Which companies dominate the intravenous catheters landscape?

Key players in the intravenous catheters market include Becton, Dickinson and Company (United States), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), Teleflex Incorporated (United States), Terumo Corporation (Japan), Boston Scientific Corporation (United States), ICU Medical, Inc. (United States), Nipro Corporation (Japan), Smiths Medical (United Kingdom), Vygon (France)
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →